This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Risk management


The life sciences industry (pharmaceuticals, biotechnology and medical devices) faces significant risks inherent in the business. Executives and directors must address the continual demands of a multitude of constituents – regulators, investors, partners, insurers, physicians, patients, lawyers, the media and others. Meeting these needs adds complexity and heightens risk, and as these risks converge and overlap, managing risk becomes simultaneously more difficult and more important.

Risk management challenges have been underestimated in the past by the life sciences sector and include:

  • Changing and increasingly complex regulations
  • Unwanted disclosure and publication of clinical trial results
  • Illegal copies of products and patents
  • Insufficient control of third parties
  • Data leakage in research and development

Life sciences companies or institutes need to focus on:

  • Ensuring that sensitive information is properly monitored
  • Ensuring supply chain integrity
  • Finding the best way to manage risks by an appropriate:
    • Organisation
    • Risk management IT system
    • Set of processes
  • Safeguarding brand image and introducing anti-counterfeiting solutions

Deloitte service offering

To help life sciences organisations to control quality and risk management, Deloitte service offering includes:

  • Defining a global risk map and identifying key risks
  • Defining risk management organisation, policies and processes
  • Supporting the selection of an appropriate risk management system
  • Giving individualised risk management coaching and training


  • Laurent Berliner
    Partner - EMEA Financial Services Industry Enterprise Risk Services Leader
  • Ruth Bültmann
    Partner - Strategy & Corporate Finance
  • Michaël Blaise
    Directeur - Business Risk
  • Jérôme Sosnowski
    Directeur - Business Risk
  • David Cau
    Directeur - Business Risk

More Learn more

  • Internal audit outsourcing and cosourcing - A flexible solution for self-managed AIFs | Brochure
    The Directive has introduced a specific obligation for self-managed AIFs to adopt a permanent Internal Audit function, as specified in the application form for self-managed AIFs.
  • Internal audit outsourcing and cosourcing | Deloitte solution
    In Luxembourg, the EU Directive on AIFMs has emerged as one of the most challenging new regulations for non-UCITS management companies.
  • Internal audit outsourcing and cosourcing - A response tailored to your needs | Brochure
    More than ever, internal auditing must be at the centre of corporate strategy and its smooth implementation.
  • Choosing the best risk management and internal audit tool - Finding the key to success | Brochure
    As risk management and internal audit practices are developed, the issue of investing in an automated solution to improve efficiency will arise.



Stay connected:
Get connected
Share your comments
More on Deloitte Luxembourg
Learn about our site

Recently published